Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]
Ann Oncol. 2022 Mar;33(3):355.
doi: 10.1016/j.annonc.2021.12.008.
Epub 2022 Jan 7.
1 West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany.
2 West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany; University of Cologne, Cologne, Germany. Electronic address: [email protected].
3 Institute of Pathology, Medical School Hannover, Hannover, Germany.
4 Department of Gynecology and Obstetrics, University Clinics Tuebingen, Tuebingen, Germany.
5 Breast Center Ostbayern, Deggendorf, Germany.
6 Breast Center, Clinics Essen-Mitte, Essen, Germany.
7 Rotkreuz Clinics Munich Breast Center, Munich, Germany.
8 Department of Oncology Evangelical Waldkrankenhaus Berlin, Berlin, Germany.
9 Department of Gynecology and Obstetrics, Evangelical Hospital, Ludwigsfelde, Germany.
10 Department of Gynecology and Obstetrics, University Clinics RWTH, Aachen, Germany.
11 Breast Center, Evangelical Hospital Johanniter, Stendal, Germany.
12 Breast Center, St. Elisabeth Hospital Cologne, Cologne, Germany.
13 Oncology Practice Network, Troisdorf, Germany.
14 Department of Gynecology and Obstetrics, University Clinics Rostock, Suedstadt, Germany.
15 Breast Center, Evangelical Hospital Gelsenkirchen, Gelsenkirchen, Germany.
16 Department of Gynecology and Obstetrics, University Clinics Schleswig-Holstein/Campus Luebeck, Luebeck, Germany; Charite Berlin, Germany.
17 Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.
19 West German Study Group GmbH, Moenchengladabach, Germany.
20 University of Cologne, Cologne, Germany.
21 West German Study Group GmbH, Moenchengladabach, Germany; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.